Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Silverchair Information Systems full text link Silverchair Information Systems Free PMC article
Full text links

Actions

Share

Review
.2015 Feb;13(1):51-4.
doi: 10.1016/j.gpb.2015.01.002. Epub 2015 Feb 19.

Web resources for pharmacogenomics

Affiliations
Review

Web resources for pharmacogenomics

Guoqing Zhang et al. Genomics Proteomics Bioinformatics.2015 Feb.

Abstract

Pharmacogenomics is the study of the impact of genetic variations or genotypes of individuals on their drug response or drug metabolism. Compared to traditional genomics research, pharmacogenomic research is more closely related to clinical practice. Pharmacogenomic discoveries may effectively assist clinicians and healthcare providers in determining the right drugs and proper dose for each patient, which can help avoid side effects or adverse reactions, and improve the drug therapy. Currently, pharmacogenomic approaches have proven their utility when it comes to the use of cardiovascular drugs, antineoplastic drugs, aromatase inhibitors, and agents used for infectious diseases. The rapid innovation in sequencing technology and genome-wide association studies has led to the development of numerous data resources and dramatically changed the landscape of pharmacogenomic research. Here we describe some of these web resources along with their names, web links, main contents, and our ratings.

Keywords: Adverse reaction; Drug response; Pharmacogenetics; Pharmacogenomics.

Copyright © 2015 The Authors. Production and hosting by Elsevier Ltd.. All rights reserved.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wang L., McLeod H.L., Weinshilboum R.M. Genomics and drug response. N Engl J Med. 2011;364:1144–1153. - PMC - PubMed
    1. Weinshilboum R.M., Wang L. Pharmacogenetics and pharmacogenomics: development, science, and translation. Annu Rev Genomics Hum Genet. 2006;7:223–245. - PubMed
    1. Mega J.L., Simon T., Collet J.P., Anderson J.L., Antman E.M., Bliden K., et al. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA. 2010;304:1821–1830. - PMC - PubMed
    1. Daly A.K., King B.P. Pharmacogenetics of oral anticoagulants. Pharmacogenetics. 2003;13:247–252. - PubMed
    1. Ginsburg G.S., Voora D. The long and winding road to warfarin pharmacogenetic testing. J Am Coll Cardiol. 2010;55:2813–2815. - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full text links
Silverchair Information Systems full text link Silverchair Information Systems Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp